Skip to content

Clinical trials

Terminated Carcinoma, Non-Small-Cell Lung trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Terminated Country / region: Poland Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20054
20062
20071
20085
20092
20102
20112
20124
20131
20142
20154
20161
20171
20184
20195
20202
20212
20224
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated53

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Pfizer6
Hoffmann-La Roche5
Bristol-Myers Squibb3
GlaxoSmithKline3
Daiichi Sankyo2
ETOP IBCSG Partners Foundation2
MacroGenics2
Merck Sharp & Dohme LLC2
Synta Pharmaceuticals Corp.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung53
Lung Neoplasms9
Neoplasm Metastasis6
Melanoma5
Neoplasms5
Carcinoma4
Squamous Cell Carcinoma of Head and Neck4
Small Cell Lung Carcinoma3
Triple Negative Breast Neoplasms3
Adenocarcinoma of Lung2

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.